Clinical presentation, diagnostic findings and outcome of dogs undergoing surgical resection for intracranial meningioma: 101 dogs
Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies...
Saved in:
Published in | BMC veterinary research Vol. 18; no. 1; p. 88 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
07.03.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome.
A hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time.
This study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. |
---|---|
AbstractList | Abstract Background Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome. Results A hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time. Conclusions This study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome. A hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time. This study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome. A hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time. This study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. BACKGROUNDMeningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome. RESULTSA hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time. CONCLUSIONSThis study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. Background Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome. Results A hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time. Conclusions This study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. Keywords: Meningioma, Craniotomy, Hydroxyurea, Ultrasonic aspirator, Intracranial, Survival, Transfrontal, Rostrotentorial Abstract Background Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the surgical resection of an intracranial meningioma together with the influence of adjunctive therapies. Whilst there have been several studies reporting the long-term outcome of intracranial meningioma resection following surgery alone, surgery with the use of an ultrasonic aspirator, surgery combined with radiotherapy and surgery combined with the addition of hydroxyurea, it is currently unclear which type of adjunctive therapy is associated with the most favourable outcomes. The objective of this study is to describe the presentation and outcome of dogs undergoing surgery for the resection of an intracranial meningioma and the effect of clinical factors, adjunctive therapies and meningioma histopathological subtype on the long-term outcome. Results A hundred and one dogs that had intracranial surgery for meningioma resection were investigated from four referral centres. 94% of dogs survived to hospital discharge with a median survival time of 386 days. Approximately 50% of dogs survived for less than a year, 25% survived between 1 and 2 years, 15% survived between 2 and 3 years and 10% survived for greater than 3 years following discharge from hospital. One or more adjunctive therapies were used in 75 dogs and the analysis of the data did not reveal a clear benefit of a specific type of adjunctive therapy. Those dogs that had a transfrontal approach had a significantly reduced survival time (MST 184 days) compared to those dogs that had a rostrotentorial approach (MST 646 days; p < 0.05). There was no association between meningioma subtype and survival time. Conclusions This study did not identify a clear benefit of a specific type of adjunctive therapy on the survival time. Dogs that had a transfrontal approach had a significantly reduced survival time. Intracranial surgery for meningioma resection offers an excellent prognosis for survival to discharge from hospital with a median long term survival time of 386 days. |
ArticleNumber | 88 |
Audience | Academic |
Author | Plessas, Ioannis N De Decker, Steven Garosi, Laurent Forward, Alexander K Cherubini, Giunio Bruto Volk, Holger Andreas Harcourt-Brown, Tom |
Author_xml | – sequence: 1 givenname: Alexander K surname: Forward fullname: Forward, Alexander K email: alex.forward@vetspecialists.co.uk organization: Davies Veterinary Specialists, Higham Gobion, Hitchin, SG5 3HR, UK. alex.forward@vetspecialists.co.uk – sequence: 2 givenname: Holger Andreas surname: Volk fullname: Volk, Holger Andreas organization: Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, 30559, Hannover, Germany – sequence: 3 givenname: Giunio Bruto surname: Cherubini fullname: Cherubini, Giunio Bruto organization: Dick White Referrals, Station Farm, London Road, Six Mile Bottom, Cambridgeshire, CB8 0UH, UK – sequence: 4 givenname: Tom surname: Harcourt-Brown fullname: Harcourt-Brown, Tom organization: Langford Small Animal Referral Hospital, Langford House, Langford, Bristol, BS40 5DU, UK – sequence: 5 givenname: Ioannis N surname: Plessas fullname: Plessas, Ioannis N organization: Davies Veterinary Specialists, Higham Gobion, Hitchin, SG5 3HR, UK – sequence: 6 givenname: Laurent surname: Garosi fullname: Garosi, Laurent organization: Vet Oracle Teleradiology, Bedford, UK – sequence: 7 givenname: Steven surname: De Decker fullname: De Decker, Steven organization: Department of Clinical Science and Services, Royal Veterinary College, University of London, North Mymms, AL9 7TA, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35249530$$D View this record in MEDLINE/PubMed |
BookMark | eNptkktr3DAUhU1JaR7tH-iiCLrpIk71ttRFIQxpGwh0066FrIerYEtTyQ7Mtr-88kwaMlC8kLn33I97pHPenMQUXdO8RfAKIcE_FoQl6lqIcQsJErjdvWjOUEd5yxEVJ8_-T5vzUu4hpFR2_FVzShimkhF41vzZjCEGo0ewza64OOs5pHgJbNBDTGUOBvgQbYhDATpakJbZpMmB5IFNtbZE6_KQah-UJQ970goyKwb4lEGIc9Ym6xhqa3KxSkOa9CeAINozXjcvvR6Le_N4XjQ_v9z82Hxr775_vd1c37WGETZXH7BjnPQdNghRrqHttBfYCEeo0LIXjEpjTU-slx5bg5xmru-xJdAZKT25aG4PXJv0vdrmMOm8U0kHtS-kPCidq-HRKcgdYkI6CSmnCPoes55jahFjhPQSV9bnA2u79JOzxq0mxyPocSeGX2pID0rI9RVgBXx4BOT0e3FlVlMoxo2jji4tRWFOuBAMI1Gl7w_SQdfVQvRpvdBVrq65lAxKidaNrv6jqp91UzA1OD7U-tEAPgyYnErJzj9tj6Ba86UO-VI1X2qfL7WrQ--e-34a-Rco8hf4888C |
CitedBy_id | crossref_primary_10_1111_jvim_16789 crossref_primary_10_3389_fvets_2022_956648 crossref_primary_10_3389_fvets_2023_1273122 crossref_primary_10_17555_jvc_2023_40_5_341 crossref_primary_10_3390_life13122284 crossref_primary_10_3390_ani14121753 |
Cites_doi | 10.4132/jptm.2019.11.05 10.1007/s00401-007-0243-4 10.1111/j.1939-1676.2008.00042.x 10.3171/2014.10.JNS14502 10.1111/vco.12054 10.1111/vsu.12340 10.1016/j.ijrobp.2009.01.066 10.1053/jvet.2001.25867 10.1111/j.1532-950X.2014.12238.x 10.1016/j.jfms.2006.01.002 10.1111/j.1532-950X.1994.tb00452.x 10.3389/fonc.2019.01151 10.2460/javma.2002.221.1597 10.1016/j.jfms.2006.01.005 10.14791/btrt.2017.5.2.77 10.3340/jkns.2012.52.6.517 10.1111/jvim.13617 10.3171/FOC-07/10/E4 10.1111/j.1939-1676.2006.tb02913.x 10.1002/jemt.22409 10.1111/j.1748-5827.2007.00467.x 10.1354/vp.39-3-311 10.1292/jvms.14-0001 10.1292/jvms.12-0373 10.2460/javma.229.3.394 10.2460/javma.2000.216.701 10.1111/j.1939-1676.2006.tb02912.x 10.1111/j.1939-1676.2003.tb02525.x 10.1111/vru.12286 10.1016/j.tvjl.2011.10.008 10.1292/jvms.69.1313 10.4314/ovj.v7i4.14 10.1016/j.jfms.2006.07.001 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: The Author(s) 2022 |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1186/s12917-022-03182-y |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Veterinary Medicine |
EISSN | 1746-6148 |
EndPage | 88 |
ExternalDocumentID | oai_doaj_org_article_06e1589e9046410fb25b624d15533b92 A699509912 10_1186_s12917_022_03182_y 35249530 |
Genre | Journal Article |
GeographicLocations | United Kingdom |
GeographicLocations_xml | – name: United Kingdom |
GroupedDBID | --- -A0 0R~ 23N 2WC 2XV 3V. 53G 5GY 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAHBH AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS APEBS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECGQY EMB EMK EMOBN ESX EYRJQ F5P FYUFA GROUPED_DOAJ HMCUK HYE IAG IAO IHR INH INR ITC ITG ITH KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP WOQ WOW XSB AAYXX CITATION ABVAZ AFGXO AFNRJ 7X8 5PM |
ID | FETCH-LOGICAL-c535t-6107563b72c1146a0d7af82c8e348a9b8549cdcb3df9f2dc1ea5ebb2d30ec99f3 |
IEDL.DBID | RPM |
ISSN | 1746-6148 |
IngestDate | Fri Oct 04 13:12:19 EDT 2024 Tue Sep 17 21:27:17 EDT 2024 Sat Aug 17 02:55:04 EDT 2024 Fri Feb 23 00:10:10 EST 2024 Fri Feb 02 04:23:52 EST 2024 Fri Sep 13 03:02:57 EDT 2024 Sat Sep 28 08:23:14 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Intracranial Transfrontal Rostrotentorial Craniotomy Hydroxyurea Ultrasonic aspirator Survival Meningioma |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c535t-6107563b72c1146a0d7af82c8e348a9b8549cdcb3df9f2dc1ea5ebb2d30ec99f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900440/ |
PMID | 35249530 |
PQID | 2636885218 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_06e1589e9046410fb25b624d15533b92 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8900440 proquest_miscellaneous_2636885218 gale_infotracmisc_A699509912 gale_infotracacademiconefile_A699509912 crossref_primary_10_1186_s12917_022_03182_y pubmed_primary_35249530 |
PublicationCentury | 2000 |
PublicationDate | 2022-03-07 |
PublicationDateYYYYMMDD | 2022-03-07 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC veterinary research |
PublicationTitleAlternate | BMC Vet Res |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | A Shores (3182_CR13) 1991; 2 AH Ropper (3182_CR10) 2005 JJ Greco (3182_CR2) 2006; 229 SR Platt (3182_CR25) 2006; 20 HW Jung (3182_CR7) 2014; 76 DJ Marino (3182_CR15) 2014; 43 LE Gordon (3182_CR28) 1994; 23 BA Fransson (3182_CR39) 2001; 30 MS Kim (3182_CR19) 2012; 52 AP Théon (3182_CR20) 2000; 216 A Tomek (3182_CR27) 2006; 8 F Forterre (3182_CR33) 2006; 8 K Fatima (3182_CR36) 2014; 77 S Tamura (3182_CR5) 2007; 69 JM Snyder (3182_CR29) 2006; 20 A Ijiri (3182_CR17) 2014; 76 AD Miller (3182_CR1) 2019; 9 A Suñol (3182_CR12) 2017; 7 J Moliterno (3182_CR34) 2015; 123 J Kim (3182_CR18) 2017; 5 E Scarpante (3182_CR24) 2016; 57 DI Jung (3182_CR6) 2008; 25 P Montoliu (3182_CR30) 2006; 135 AK Forward (3182_CR40) 2018; 00 F Forterre (3182_CR32) 2007; 9 MT Troxel (3182_CR26) 2003; 17 DN Louis (3182_CR35) 2007; 114 YS Lee (3182_CR38) 2020; 54 A Koestner (3182_CR8) 1999 L Motta (3182_CR3) 2012; 192 DN Louis (3182_CR37) 2007 BK Sturges (3182_CR11) 2008; 22 MP Korah (3182_CR23) 2010; 76 TW Axlund (3182_CR4) 2002; 221 L Rogers (3182_CR22) 2007; 23 RP Cavanaugh (3182_CR14) 2008; 49 H Hu (3182_CR16) 2015; 29 MA Keyerleber (3182_CR21) 2013; 13 KF Barnhart (3182_CR31) 2002; 39 S Cameron (3182_CR9) 2015; 44 |
References_xml | – volume: 54 start-page: 45 issue: 1 year: 2020 ident: 3182_CR38 publication-title: J Pathol Transl Med doi: 10.4132/jptm.2019.11.05 contributor: fullname: YS Lee – volume: 114 start-page: 97 year: 2007 ident: 3182_CR35 publication-title: Acta Neuropathol doi: 10.1007/s00401-007-0243-4 contributor: fullname: DN Louis – volume: 22 start-page: 86 year: 2008 ident: 3182_CR11 publication-title: J Vet Intern Med doi: 10.1111/j.1939-1676.2008.00042.x contributor: fullname: BK Sturges – volume: 2 start-page: 89 year: 1991 ident: 3182_CR13 publication-title: Prog Vet Neurol contributor: fullname: A Shores – volume: 123 start-page: 23 issue: 1 year: 2015 ident: 3182_CR34 publication-title: J Neurosurg doi: 10.3171/2014.10.JNS14502 contributor: fullname: J Moliterno – volume: 13 start-page: 385 issue: 4 year: 2013 ident: 3182_CR21 publication-title: Vet Comp Oncol doi: 10.1111/vco.12054 contributor: fullname: MA Keyerleber – volume: 44 start-page: 772 issue: 6 year: 2015 ident: 3182_CR9 publication-title: Vet Surg doi: 10.1111/vsu.12340 contributor: fullname: S Cameron – start-page: 559 volume-title: Adams and Victor’s principles of neurology year: 2005 ident: 3182_CR10 contributor: fullname: AH Ropper – start-page: 22 volume-title: Histological classification of tumors of the nervous system of domestic animals WHO international classification of tumors of domestic animals, vol. 5 year: 1999 ident: 3182_CR8 contributor: fullname: A Koestner – volume: 76 start-page: 181 issue: 1 year: 2010 ident: 3182_CR23 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2009.01.066 contributor: fullname: MP Korah – volume: 30 start-page: 432 year: 2001 ident: 3182_CR39 publication-title: Vet Surg doi: 10.1053/jvet.2001.25867 contributor: fullname: BA Fransson – volume: 00 start-page: 1 year: 2018 ident: 3182_CR40 publication-title: Vet Surg contributor: fullname: AK Forward – volume: 43 start-page: 888 issue: 7 year: 2014 ident: 3182_CR15 publication-title: Vet Surg doi: 10.1111/j.1532-950X.2014.12238.x contributor: fullname: DJ Marino – volume: 8 start-page: 227 issue: 4 year: 2006 ident: 3182_CR33 publication-title: J Feline Med Surg doi: 10.1016/j.jfms.2006.01.002 contributor: fullname: F Forterre – volume: 23 start-page: 94 year: 1994 ident: 3182_CR28 publication-title: Vet Surg doi: 10.1111/j.1532-950X.1994.tb00452.x contributor: fullname: LE Gordon – volume: 25 start-page: 514 year: 2008 ident: 3182_CR6 publication-title: J Vet Clin contributor: fullname: DI Jung – volume: 9 start-page: 1333 year: 2019 ident: 3182_CR1 publication-title: Front Oncol doi: 10.3389/fonc.2019.01151 contributor: fullname: AD Miller – volume: 221 start-page: 1597 issue: 11 year: 2002 ident: 3182_CR4 publication-title: J Am Vet Med Assoc doi: 10.2460/javma.2002.221.1597 contributor: fullname: TW Axlund – volume: 8 start-page: 243 year: 2006 ident: 3182_CR27 publication-title: J Feline Med Surg doi: 10.1016/j.jfms.2006.01.005 contributor: fullname: A Tomek – volume: 5 start-page: 77 issue: 2 year: 2017 ident: 3182_CR18 publication-title: Brain Tumor Res Treat doi: 10.14791/btrt.2017.5.2.77 contributor: fullname: J Kim – volume: 52 start-page: 517 issue: 6 year: 2012 ident: 3182_CR19 publication-title: J Korean Neurosurg Soc doi: 10.3340/jkns.2012.52.6.517 contributor: fullname: MS Kim – start-page: 164 volume-title: WHO classification of Tumours of the central nervous system year: 2007 ident: 3182_CR37 contributor: fullname: DN Louis – volume: 29 start-page: 1456 issue: 6 year: 2015 ident: 3182_CR16 publication-title: J Vet Intern Med doi: 10.1111/jvim.13617 contributor: fullname: H Hu – volume: 23 start-page: E4 issue: 4 year: 2007 ident: 3182_CR22 publication-title: Neurosurg Focus doi: 10.3171/FOC-07/10/E4 contributor: fullname: L Rogers – volume: 20 start-page: 669 year: 2006 ident: 3182_CR29 publication-title: J Vet Intern Med doi: 10.1111/j.1939-1676.2006.tb02913.x contributor: fullname: JM Snyder – volume: 77 start-page: 862 issue: 11 year: 2014 ident: 3182_CR36 publication-title: Microsc Res Tech doi: 10.1002/jemt.22409 contributor: fullname: K Fatima – volume: 49 start-page: 244 issue: 5 year: 2008 ident: 3182_CR14 publication-title: J Small Anim Pract doi: 10.1111/j.1748-5827.2007.00467.x contributor: fullname: RP Cavanaugh – volume: 39 start-page: 311 year: 2002 ident: 3182_CR31 publication-title: Vet Pathol doi: 10.1354/vp.39-3-311 contributor: fullname: KF Barnhart – volume: 135 start-page: 07 issue: 200–207 year: 2006 ident: 3182_CR30 publication-title: J Comp Pathol contributor: fullname: P Montoliu – volume: 76 start-page: 1545 issue: 11 year: 2014 ident: 3182_CR7 publication-title: J Vet Med Sci doi: 10.1292/jvms.14-0001 contributor: fullname: HW Jung – volume: 76 start-page: 331 issue: 3 year: 2014 ident: 3182_CR17 publication-title: J Vet Med Sci doi: 10.1292/jvms.12-0373 contributor: fullname: A Ijiri – volume: 229 start-page: 394 year: 2006 ident: 3182_CR2 publication-title: J Am Vet Med Assoc doi: 10.2460/javma.229.3.394 contributor: fullname: JJ Greco – volume: 216 start-page: 701 issue: 5 year: 2000 ident: 3182_CR20 publication-title: J Am Vet Med Assoc doi: 10.2460/javma.2000.216.701 contributor: fullname: AP Théon – volume: 20 start-page: 663 year: 2006 ident: 3182_CR25 publication-title: J Vet Intern Med doi: 10.1111/j.1939-1676.2006.tb02912.x contributor: fullname: SR Platt – volume: 17 start-page: 850 year: 2003 ident: 3182_CR26 publication-title: J Vet Intern Med doi: 10.1111/j.1939-1676.2003.tb02525.x contributor: fullname: MT Troxel – volume: 57 start-page: E5 issue: 1 year: 2016 ident: 3182_CR24 publication-title: Vet Radiol Ultrasound doi: 10.1111/vru.12286 contributor: fullname: E Scarpante – volume: 192 start-page: 153 issue: 2 year: 2012 ident: 3182_CR3 publication-title: Vet J doi: 10.1016/j.tvjl.2011.10.008 contributor: fullname: L Motta – volume: 69 start-page: 1313 issue: 12 year: 2007 ident: 3182_CR5 publication-title: J Vet Med Sci doi: 10.1292/jvms.69.1313 contributor: fullname: S Tamura – volume: 7 start-page: 375 issue: 4 year: 2017 ident: 3182_CR12 publication-title: Open Vet J doi: 10.4314/ovj.v7i4.14 contributor: fullname: A Suñol – volume: 9 start-page: 36 issue: 1 year: 2007 ident: 3182_CR32 publication-title: J Feline Med Surg doi: 10.1016/j.jfms.2006.07.001 contributor: fullname: F Forterre |
SSID | ssj0044976 |
Score | 2.35911 |
Snippet | Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs following the... Abstract Background Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of... Background Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs... BACKGROUNDMeningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of dogs... Abstract Background Meningioma is the most common primary brain neoplasm in dogs. Further information is required regarding the expected long-term prognosis of... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 88 |
SubjectTerms | Care and treatment Craniotomy Diagnosis Diseases Dogs Hydroxyurea Intracranial Meningioma Patient outcomes Survival Ultrasonic aspirator |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV27b9YwELdQJxYEpUBoQUaqxABRE9txbLaCqKpK7URRN8vPUokm1fcYuvKXc2fnK1_EwMKas6yL73cPy_cg5FAH2zaxj7Xi3tfCBl9b7VMtvA6tTn1qcxPX8wt5einOrrqrrVFfmBNW2gOXgztqZGw7paPGN7i2SY51TjIRcN4Nd7pY37bbXKaKDRYCvOymREbJoyV4NbDGmLmOIGb1_cwN5W79f9vkLac0T5jc8kAnT8mTKXSkx4XlZ-RRHHbJ7nfMZ8lFtfR8eid_Tn5N7T5_0rs_5UXDRxpKYh1sQPNj9XC9pHYIdFyvAHmRjomGEb5hZdniegQ6Xa4X2ThS3CgXQVCIc-kNsujB0QF-6W3Mc4_GW_uJgvLlPfbI5cnXb19O62naQu073q3gDgnRg-SuZx4rlW0TepsU8ypyoax2Cm6SPnjHQ9KJBd9G20XnWOBN9Fon_oLsDOMQXxHagZkNToqY2igkSEB5qWzC2I5ZoUNFPmwO39yVphomX0aUNEVUBkRlsqjMfUU-o3weVmJD7PwBYGImmJh_waQi71G6BtUWz8dO1QfAMDbAMsdSa4iddAsrD2YrQd38jPxugw-DJMxRG-K4XhomuVQKwiFVkZcFLw88Q5iLibxNRfoZkmY_NacMNz9yt2-l81jw1__jFPbJY1aUoG76A7KzWqzjGwiqVu5t1p_fQxwf0g priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKuXBBUF6BgoyExAECie04NhJCBVFVSMuJRb1Zjh9LpTYp2V2JvfLLmXGySyMqrrE1cjzfeD7L8yDkhfa2LEIdcsWdy4X1LrfaxVw47Usd61imIq6zr_JkLr6cVqd7ZNvuaNzA5bVXO-wnNe_P3_z6ufkABv8-GbySb5fgs-Csxbh0hCjLNzfITSa4QMTPxO5VQQidms0BCZc5FsDcJtFcK2PiqFI9_39P7StuaxpSecVHHd8ht0dySY8GNNwle6E9IAffMeIlpd3S2fiSfo_8HguCntPLvwlI7Wvqh9A7EEDTc3a7WFLbetqtV4DNQLtIfQffMPesX3QwTpfrPh2fFAWlNAkKTJie4RIduEJAOL0IqTNSd2HfUTDPJOM-mR9__vbpJB_7MeSu4tUKtgz4heRNzRzmMtvC1zYq5lTgQlndKLhrOu8a7qOOzLsy2Co0DfO8CE7ryB-Q_bZrwyNCKziIfSNFiGUQEjSgnFQ2IvtjVmifkVfbzTeXQ9kNk64rSppBVQZUZZKqzCYjH1E_u5lYMjt96PqFGS3QFDKUldJB42NuWcSGVY1kwmPjJN5olpGXqF2DUMP9sWN-AiwYS2SZI6k1sCtdwszDyUwwSDcZfr7Fh8EhjGJrQ7deGia5VAoIk8rIwwEvuzUDEcZQ3yIj9QRJk5-ajrRnP1I9cKVT4_DH_1_WE3KLDfDOi_qQ7K_6dXgKhGrVPEtW8gc_Zx45 priority: 102 providerName: Scholars Portal |
Title | Clinical presentation, diagnostic findings and outcome of dogs undergoing surgical resection for intracranial meningioma: 101 dogs |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35249530 https://search.proquest.com/docview/2636885218 https://pubmed.ncbi.nlm.nih.gov/PMC8900440 https://doaj.org/article/06e1589e9046410fb25b624d15533b92 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJCiWXkqavbdJFhUIPrbO2LMtSb9mQEAobQmjK0ovQc7OQtZd9HHLtL-9IttOY3nrxwZKF7PnmIeubEUKfhFVZ6kqX8NyYhCprEiWMT6gRNhO-9Fks4jq5Ype39Pu0mO6gosuFiaR9o-cn1f3ipJrfRW7lcmFGHU9sdD054yKelDzaRbtlnndL9Mb8UgoOtsuO4Wy0BocGhjiQ1gN-SfKwj55D1BF4lWnPGcWa_f9a5ieuqU-bfOKHLg7QizaAxKfNRF-iHVcdosOfgdUSU2vxpN0tf4V-t0U_7_Hyb5JR9RXbhl4HA-C4ZV3N1lhVFtfbDeDP4dpjW8O9kF-2mtXQjtfbVTSROAwUUyEwRLt4HqZowN0BivHCxdOP6oX6hkEF4xiv0e3F-Y-zy6Q9cyExRV5sYCUJMQTLdUlMyFdWqS2V58Rwl1OuhOawnjTW6Nx64Yk1mVOF05rYPHVGCJ-_QXtVXbl3CBdgbK1m1PnMUQbC4IZx5UOERxQVdoC-dB9fLpvSGjIuSTiTjdQkSE1GqcmHARoH-Tz2DGWx4416NZMtOGTKXFZw4UTYsM1Sr0mhGaE2HI6Ua0EG6HOQrgzKG76PanMQYMKhDJY8ZUJABCUy6Hnc6wlKZ3rNHzt8yNAUmGqVq7drSVjOOIegiA_Q2wYvj3PuYDdAZQ9JvZfqt4AKxJrfLeTf__eTR2ifNEqQpOUx2tustu4DxFMbPQQtmpZD9Gx8fnV9M4x_JeA6oRyuN-Nfw6hffwBwXydp |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27955,27956,31753,33778,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXHuW1UMBISBwgu4mTODa3UlEt0K04tFVvlp_Lim6y2k0O5cgvZ-wkpYETXD2OZcffPCx_M0boNTcyiW1hI5ZqHWXS6Ehy7aJMc5NwV7gkFHGdHdPpafb5PD_fQnmfCxNI-1otxuXFclwuvgVu5WqpJz1PbPJ1dsB4eCl5cgPdBH0leX9Ibw1wloGL7fNjGJ1swKWBKfa0dY9gEl3uoFsQd3hmZTxwR6Fq_9-2-ZpzGhInr3miw7vorF9DS0D5Pm5qNdY__ijv-M-LvIfudLEp3m_F99GWLXfR7pknzISsXTzrLuIfoJ9dPdELvPqdv1S-w6Zl7sEAONyGl_MNlqXBVVMDtC2uHDYVtPnUtfW8AjneNOtgfbEfKGRZYAik8cKvXYMnBQXBSxseVqqW8j0G7Q5jPESnhx9PDqZR95xDpPM0r-GQCuEJTVVBtE-FlrEppGNEM5tmTHLF4KiqjVapcdwRoxMrc6sUMWlsNecufYS2y6q0TxDOwY4bRTPrEptR2GWmKZPOB49EZtyM0Nt-V8WqrdohwmmHUdHCQQAcRICDuByhD37jr3r6ituhoVrPRbclIqY2yRm33N8FJ7FTJFeUZMa_u5QqTkbojYeN8HbB_x_ZpTfAhH2FLbFPOYfgjCfQc2_QE_RZD8SveuAJL_IkuNJWzUYQmlLGIN5iI_S4BeLVnHs8j1AxgOhgUUMJAC-UE--A9vS_v3yJbk9PZkfi6NPxl2doh7SaFsXFHtqu1419DmFbrV4EJf0Fd-JD-Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgSNMuDAaMjgFGQuIAaRMncWxuY1CNj047MDRxsfxZKtakatPDOPKX8-wko4HbrrZj2fHvfVj-vfcQesmNTGJb2IilWkeZNDqSXLso09wk3BUuCUlcJ6f05Dz7dJFfbJT6CqR9rWbD8nI-LGc_ArdyMdejjic2OpscMx4qJY8Wxo1uozsgs6ToLuqNEs4yMLNdjAyjoxWYNVDHnrruUUyiqx20Db6HZ1fGPZMUMvf_r583DFSfPLlhjca76Hu3j4aE8nO4rtVQ__onxeONNnoP3W19VHzUDLmPbtlyD-1988SZEL2LJ-2D_AP0u80reokXf-OYyjfYNAw-mACHV_FyusKyNLha1wBxiyuHTQVtPoRtOa2gH6_Wy6CFsZ8oRFtgcKjxzO9fg0UFQcFzGwosVXP5FoOUhzkeovPxh6_HJ1Fb1iHSeZrXcFkFN4WmqiDah0TL2BTSMaKZTTMmuWJwZdVGq9Q47ojRiZW5VYqYNLaac5c-QltlVdrHCOegz42imXWJzSicNNOUSeedSCIzbgbodXeyYtFk7xDh1sOoaCAhABIiQEJcDdA7f_jXI33m7dBQLaeiPRYRU5vkjFvu34ST2CmSK0oy4-svpYqTAXrloSO8fvD_R7ZhDrBgn2lLHFHOwUnjCYw87I0Euda97hcd-ITv8mS40lbrlSA0pYyB38UGaL8B4_WaO0wPUNGDaW9T_R4AX0gr3oLt4MZfPkfbZ-_H4svH089P0A5phC2Ki0O0VS_X9il4b7V6FuT0D30RRnk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+presentation%2C+diagnostic+findings+and+outcome+of+dogs+undergoing+surgical+resection+for+intracranial+meningioma%3A+101+dogs&rft.jtitle=BMC+veterinary+research&rft.au=Forward%2C+Alexander+K&rft.au=Volk%2C+Holger+Andreas&rft.au=Cherubini%2C+Giunio+Bruto&rft.au=Harcourt-Brown%2C+Tom&rft.date=2022-03-07&rft.pub=BioMed+Central+Ltd&rft.issn=1746-6148&rft.eissn=1746-6148&rft.volume=18&rft.issue=1&rft_id=info:doi/10.1186%2Fs12917-022-03182-y&rft.externalDocID=A699509912 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1746-6148&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1746-6148&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1746-6148&client=summon |